Cardiovascular Angiogenic Gene Therapy Gets Fast Track Status – Monthly Prescribing Reference (registration)
|
Cardiovascular Angiogenic Gene Therapy Gets Fast Track Status
Monthly Prescribing Reference (registration) The trial is intended to examine Generx as a one-time treatment for improving exercise tolerance in patients who have angina that is refractory to standard medical therapy and not amenable to conventional revascularization procedures (coronary artery … |
